Print

Healthcare Services Insights

How Technology Can Help Pharma Companies and Clinical Trial Outsourcers to Win
Volume XIX, Issue 43 | July 10, 2017 | By: Ben Faircloth , Andre Valente

In this Executive Insights, L.E.K. Consulting explores how the use of technology to increase efficiency and enhance quality is transforming the pharma sector. The challenge will be to determine the most effective route to offer truly differentiated services.

Beating the Health Spending Squeeze: Strategies for France’s Homecare Service Providers
Volume XIX, Issue 41 | June 29, 2017 | By: Arnaud Sergent, Serge Hovsepian , Nohmie Ben Rekassa

In this Executive Insights, L.E.K. Consulting examines how homecare providers can address pressure to reduce healthcare costs while maintaining profitability by consolidating local market share in their core segments and improving operational efficiencies.

Toward the Stick (From the Carrot): The Evolution in Medicaid MCO Pay-for-Performance Programs
Volume XIX, Issue 35 | June 6, 2017 | By: Todd Clark, Joan Kim , Neil Menzies, Catrina Pheeney

In the midst of the continuing uncertainty related to the “repeal and replace” of the Affordable Care Act (ACA), those with an eye on Medicaid programs are bracing for reduced funding in some form, whether or not they manifest in block (per capita) payments. This Executive Insights examines the range of mechanisms by states to incentivize MCO performance and includes case studies from the District of Columbia, Ohio and South Carolina.

Ambulatory Surgery Centers: Becoming Big Business
Volume XIX, Issue 25 | April 17, 2017 | By: Bill Frack, Kevin Grabenstatter , Jeff Williamson

UnitedHealthcare’s recently announced acquisition of Surgical Care Affiliates (SCA) represents the latest signal that the $30 billion ambulatory surgery center (ASC) segment is moving to the forefront of the rapidly evolving healthcare market. In this Executive Insights, L.E.K. Consulting looks at the various factors favoring further share gains for these value-oriented care facilities.

Smart Money: Outpatient Investment Opportunities Worth Pursuing
Volume XIX, Issue 18 | March 8, 2017 | By: Monish Rajpal , Andrew Kadar, Scott Miller

The ongoing transformation of traditional healthcare has compelled providers to restructure practice locations, medical affiliations and processes in order to maintain profitability without ceding market share, care quality or convenience. In this Executive Insights, we look into current outpatient trends and highlight a number of “hot topic” practices that come up for discussion frequently.

The New Old: Building a Value Proposition for the Ageing in Private Healthcare
Volume XIX, Issue 13 | February 13, 2017 | By: Jonathan Sparey , Garry Watts

The NHS is part of the fabric of Britain. However, increasing pressures on the system have resulted in an NHS which is now in crisis. Private healthcare providers have the potential to help meet the country’s growing healthcare needs by providing critical and complementary support to core NHS services. This Executive Insights examines the changing nature of the U.K.’s healthcare needs and details five key challenges private providers need to address if they are to become of greater strategic importance.

2016 Health & Wellness Study
Analysis 1 | January 25, 2017 | By: Alex Evans, Chris Randall

The 2016 Health & Wellness Study examines consumer spending preferences for nutritional supplements, personal care and healthy grocery products among Millennials, Gen X and Boomers. The study looks at category engagement, drivers of channel selection and, the potential for subscription services, as well as the success factors for private-label products.

Winning in the Next Era: Strategies for the Changing Global Healthcare Market
Volume XIX, Issue 1 | January 5, 2017 | By: Clay Heskett, Helen Chen, Peter Rosenorn, David Barrow , Verena Ahnert

Developing therapeutics and medical devices for global healthcare markets remains a risky proposition. The medical innovations now coming to market are remarkable and reflect the reaction of healthcare companies towards innovation a decade ago. Globally, the biopharma and medtech sectors are being shaped by four significant forces, which will determine the success factors for the next generation of healthcare products. In this Executive Insights, L.E.K. examines each of the key forces driving change.

What’s Next for U.S. Healthcare Under Trump?
Volume XVIII, Issue 46 | December 2, 2016 | By: Kevin Grabenstatter, Wiley Bell , Andrew Kadar

What will the transition to a Trump administration mean for the healthcare industry’s key constituents? While experts of all stripes are asserting predictions, they are typically long on speculation and short on evidence. In a moment of political uncertainty, it is most useful to know which issues and stakeholder “tensions” to watch closely. This Executive Insights will highlight some of these questions.

Poised for Growth: Prospects for Southeast Asia’s Private Healthcare Providers
Volume XVIII, Issue 34 | October 10, 2016 | By: Zafar Momin , Calvin Wijaya, Pattanit Chareonkul, Paul Bernardo

Southeast Asia (SEA) is offers opportunities for private healthcare provider investments in light of increasing demand for private health services that are supported by strong growth fundamentals and the inherent gap in public healthcare infrastructure. This Executive Insights discusses the key challenges and investment outlook.

Pages